Morning or afternoon? new study tests best time for immunotherapy
NCT ID NCT07224971
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether getting immunotherapy in the morning or afternoon changes how well it works for people with advanced lung cancer. About 350 patients will be randomly assigned to receive their treatment either before 11 AM or after 12 PM. The goal is to see if timing affects how long the cancer stays under control.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED / METASTATIC SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UPMC Hillman Cancer Center
RECRUITINGPittsburgh, Pennsylvania, 15232, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New mRNA vaccine takes on tough cancers
- Immune cells engineered to attack lung cancer show promise in early trial
- New cancer drug MBRC-101 enters human trials for Hard-to-Treat tumors
- New radioactive drug shows promise for Hard-to-Treat cancers
- Immune cell booster shows promise for Hard-to-Treat cancers
- Experimental cancer drug KZR-261 tested in early trial